3.005USD-2.12%Mkt Cap: 843.22M USDP/E: —Last update: 2026-05-26
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with un…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap843.22M USD
Enterprise Value858.11M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-244.17M USD
Revenue/Share—
Last Price3.005 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.85
PEG—
EV/EBITDA-5.09
EV/Revenue—
P/S—
P/B5.22
EPS (TTM)-0.92
EPS (Forward)-0.54
52W Range
1.94023% of range6.550
52W High6.550 USD
52W Low1.940 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-151.77%
ROA-58.57%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-143.83M USD
CapEx (TTM)938.00K USD
FCF Margin—
FCF Yield-3.52%
Net Debt-18.51M USD
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity0.49
Current Ratio1.29
Quick Ratio1.17
Book Value/Sh0.6030 USD
Cash/Share0.3630 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)8.571 USD
Target Range7.000 USD – 12.00 USD
# Analysts7
Ownership
Shares Out.278.29M
Float188.67M
Insiders6.51%
Institutions76.07%
Short Interest
Short Ratio11.5d
Short % Float27.77%
Short % Out.15.22%
Shares Short41.09M
Short (prev mo.)39.38M
Technical
SMA 503.250 (-7.5%)
SMA 2003.866 (-22.3%)
Beta2.18
S&P 52W Chg28.31%
Avg Vol (30d)4.11M
Avg Vol (10d)5.05M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—